Emilio Erazo-Fischer

Emilio Erazo-Fischer is an accomplished business leader with extensive experience in the pharmaceutical industry. Currently serving as an Operating Partner at Asabys Partners and Chief Business Officer at ALLOX since December 2024, Emilio has previously held significant roles at Boehringer Ingelheim from June 2014 to December 2024, including Director of Global Business Development & Licensing Oncology, where responsibilities included leading clinical collaborations and decision-making on franchise development. Previous positions include Manager Healthcare at Alcimed GmbH, overseeing global project delivery in R&D, Market Access, and Marketing strategy, and Senior Consultant at BioSerentia SL, where strategic corporate planning was a focus. Emilio holds degrees in Business Administration and Management from Duke University and IESE Business School, emphasizing global leadership development.